It might not really grab our attention when we work in biotech or genomics all the time, but it's worth noting how the most cutting-edge testing, things that were beyond the horizon a few years ago, now appear in mainstream media articles.
WSJ has a new update of the GRAIL Galleri multi cancer early detection test (MCED) by Alex Janin (October 25, 2023).
TIME has a piece on the Artera AI test, used for prostate cancer, by Andre Esteva, CEO of Artera, with tie-ins to health equity and Cancer Moonshot. (October 18, 2023).
___
AI corner:
Halloween Special, Chat GPT rewrites an Edgar Allen Poe story, here.
